Pacira BioSciences' Deferred Taxes rose 623.95% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 42.11%. This contributed to the annual value of $20.6 million for FY2024, which is 32.06% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Deferred Taxes is $8.1 million, which was up 973.40% from $752,000 recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Deferred Taxes registered a high of $12.5 million during Q2 2024, and its lowest value of -$10.8 million during Q4 2022.
For the 3-year period, Pacira BioSciences' Deferred Taxes averaged around $4.2 million, with its median value being $3.5 million (2024).
As far as peak fluctuations go, Pacira BioSciences' Deferred Taxes plummeted by 25,417.24% in 2023, and later soared by 623.95% in 2025.
Pacira BioSciences' Deferred Taxes (Quarterly) stood at -$2.1 million in 2021, then slumped by 420.90% to -$10.8 million in 2022, then spiked by 160.89% to $6.6 million in 2023, then tumbled by 46.86% to $3.5 million in 2024, then spiked by 623.95% to $8.1 million in 2025.
Its Deferred Taxes was $8.1 million in Q3 2025, compared to $752,000 in Q2 2025 and $1.4 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value